NAMS NewAmsterdam Pharma Company N.V. - Ordinary Shares
$35.81
Price · May 20, 2026
Fundamentals as of May 7, 2026
52W Range
$17–$42
75% of range
Analyst Rating
BUY
22 analysts
Price Target
$50
+40% upside
P/E (TTM)
—
ROE
—
Net Profit Margin
—
NAMS Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$35.81
Market Cap
—
P/E (TTM)
—
EPS (TTM)
—
Revenue (TTM)
—
Div Yield
—
ROE
—
Debt/Equity
—
52W Range
$17 – $42
NAMS Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Configure
10-Year Performance Revenue, net income, margins and EPS trends
Revenue & Net Income
—
EPS
—
Free Cash Flow
—
Margins
—
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Metric
5Y trend
NAMS
Peer Median
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Metric
5Y trend
NAMS
Peer Median
Financial Health Debt, liquidity, solvency — balance sheet strength
Metric
5Y trend
NAMS
Peer Median
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Metric
5Y trend
NAMS
Peer Median
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
Metric
5Y trend
NAMS
Peer Median
NAMS Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
BUY
22 analysts
- Strong Buy 9 40.9%
- Buy 11 50.0%
- Hold 2 9.1%
- Sell 0 0.0%
- Strong Sell 0 0.0%
12-Month Price Target
13 analysts · 2026-05-14
Median
$49.67
← Below all targets
$35.81
Low
$37.75
High
$59.53
Median target
$49.67
+38.7%
Mean target
$50.20
+40.2%
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
0.04%
| Period | EPS Actual | EPS Est | Surprise |
|---|---|---|---|
| March 31, 2026 | $-0.40 | $-0.50 | 0.10% |
| Dec. 31, 2025 | $-0.62 | $-0.39 | -0.23% |
| Sept. 30, 2025 | $-0.61 | $-0.40 | -0.21% |
| June 30, 2025 | $-0.15 | $-0.50 | 0.35% |
| March 31, 2025 | $-0.34 | $-0.50 | 0.16% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement 13
| Metric | Trend | Q1 2026 |
|---|---|---|
| Revenue | $3M | |
| R&D Expense | $38M | |
| SG&A Expense | $23M | |
| Operating Expenses | $61M | |
| Operating Income | $-58M | |
| Interest Income | $6M | |
| Pretax Income | $-48M | |
| Net Income | $-48M | |
| EPS (Basic) | $-0.40 | |
| EPS (Diluted) | $-0.40 | |
| Shares (Basic) | 121,716,006 | |
| Shares (Diluted) | 121,716,006 | |
| EBITDA | $-58M |
Balance Sheet 15
| Metric | Trend | Q1 2026 |
|---|---|---|
| Cash & Equivalents | $458M | |
| Short-term Investments | $178M | |
| Prepaid Expense | $21M | |
| Current Assets | $658M | |
| PP&E (Net) | $379.0K | |
| Total Assets | $733M | |
| Accounts Payable | $8M | |
| Current Liabilities | $67M | |
| Total Liabilities | $67M | |
| Common Stock | $15M | |
| Retained Earnings | $-811M | |
| AOCI | $4M | |
| Stockholders' Equity | $665M | |
| Liabilities + Equity | $733M | |
| Shares Outstanding | 116,641,656 |
Cash Flow 8
| Metric | Trend | Q1 2026 |
|---|---|---|
| D&A | $62.0K | |
| Stock-based Comp | $18M | |
| Other Non-cash | $-227.0K | |
| Operating Cash Flow | $-31M | |
| CapEx | $38.0K | |
| Investing Cash Flow | $-12M | |
| Financing Cash Flow | $11M | |
| Free Cash Flow | $-31M |
Profitability 6
| Metric | Trend | Q1 2026 |
|---|---|---|
| Operating Margin | -1921.7% | |
| Net Margin | -1593.5% | |
| Pretax Margin | -1593.5% | |
| EBITDA Margin | -1919.7% | |
| ROA | -6.2% | |
| ROE | -6.7% |
Liquidity & Solvency 2
| Metric | Trend | Q1 2026 |
|---|---|---|
| Current Ratio | 9.8 | |
| Quick Ratio | 9.4 |
Efficiency 1
| Metric | Trend | Q1 2026 |
|---|---|---|
| Asset Turnover | 0.0 |
Valuation (TTM) 10
| Metric | Trend | Q1 2026 |
|---|---|---|
| Revenue TTM | $26M | |
| Net Income TTM | $-177M | |
| Market Cap | $3.73B | |
| P/E | -21.3 | |
| P/S | 146.4 | |
| P/B | 5.6 | |
| P / Tangible Book | 5.6 | |
| P / Cash Flow | -122.0 | |
| P / FCF | -121.8 | |
| Earnings Yield | -4.7% |
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
My Metrics Your personal watchlist — selected rows from Full Fundamentals
📊
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.